Anzeige
Mehr »
Montag, 17.11.2025 - Börsentäglich über 12.000 News
Die KI-Comeback-Story des Jahres 2025
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A402W5 | ISIN: US3179701012 | Ticker-Symbol:
NASDAQ
14.11.25 | 21:59
1,470 US-Dollar
-7,55 % -0,120
Branche
Gesundheitswesen
Aktienmarkt
Sonstige
1-Jahres-Chart
FIREFLY NEUROSCIENCE INC Chart 1 Jahr
5-Tage-Chart
FIREFLY NEUROSCIENCE INC 5-Tage-Chart

Aktuelle News zur FIREFLY NEUROSCIENCE Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
MiFirefly Neuroscience, Inc. GAAP EPS of $0.203
MiFirefly Neuroscience, Inc.: Firefly Neuroscience Reports Third Quarter 2025 Financial Results79- Quarterly performance characterized by higher revenues, reduced cost structure and improved bottom line - - Successful business integration drives 10.9% sequential quarter-over-quarter EEG/ERP...
► Artikel lesen
MiFIREFLY NEUROSCIENCE, INC. - 10-Q, Quarterly Report-
FIREFLY NEUROSCIENCE Aktie jetzt für 0€ handeln
31.10.FIREFLY NEUROSCIENCE, INC. - 8-K, Current Report1
05.09.FIREFLY NEUROSCIENCE, INC. - 8-K, Current Report4
05.09.Firefly Neuroscience, Inc.: Firefly Neuroscience Partners with HealingMaps to Offer Cognitive Electrophysiology Analytics to Over 2,500 Ketamine, Psilocybin, and TMS Clinics Across North America1
26.08.Firefly Neuroscience, Inc.: Firefly Neuroscience Successfully Deploys NVIDIA L40S GPU Acceleration to Power Next-Gen 'CLEAR' Platform10
13.08.FIREFLY NEUROSCIENCE, INC. - 10-Q, Quarterly Report2
14.07.Firefly Neuroscience Inks Deal For Use Of Its FDA-Cleared BNA Platform In Neuroscience Research1
14.07.Firefly Neuroscience stock rises on Heidelberg University collaboration4
14.07.Firefly Neuroscience partners with Heidelberg on rare genetic study2
14.07.Firefly Neuroscience, Inc.: Firefly Inks Latest Commercial Agreement for Use of its FDA-Cleared BNA Platform in Groundbreaking Precision Neuroscience Research213- Institute of Human Genetics at Heidelberg University Hospital ongoing EEG biomarker study on 15q13.3 CNVs - - Collaboration aims to uncover novel insights into the brain's functional architecture...
► Artikel lesen
23.06.Firefly Neuroscience to be added to the Russell Microcap Index4
23.06.Firefly Neuroscience, Inc.: Firefly Neuroscience to be Added to the Russell Microcap Index1
20.06.Firefly Neuroscience, Inc.: Firefly Neuroscience Researchers Uncover Powerful New Way of Objectively Measuring SCD, MCI, and Dementia in Alzheimer's Patients2
16.06.FIREFLY NEUROSCIENCE, INC. - 8-K, Current Report2
21.05.FIREFLY NEUROSCIENCE, INC. - S-8, Securities to be offered to employees in employee benefit plans4
05.05.Firefly Neuroscience, Inc.: Firefly Neuroscience Achieves Multi-Fold Database, IP Portfolio, and Commercial Footprint Expansion Through Acquisition of Evoke Neuroscience, Inc.364Builds upon Firefly's recent acceptance into the NVIDIA Connect program Marks next major step toward building a proprietary foundation model of the human brain KENMORE, N.Y., May 05, 2025 (GLOBE NEWSWIRE)...
► Artikel lesen
06.03.Hemostemix Inc.: Hemostemix and FireFly Neuroscience's Brain Network Analytics (BNA) Engage to Complete Phase 1 Vascular Dementia Clinical Trial of ACP-01430Calgary, Alberta--(Newsfile Corp. - March 6, 2025) - Hemostemix Inc. (TSXV: HEM) (OTCQB: HMTXF) (FSE: 2VF0) ("Hemostemix" or "HEM"), an autologous angiogenic stem cell company that has safely treated...
► Artikel lesen
14.01.Firefly Neuroscience, Inc.: Firefly Neuroscience Discovers Breakthrough Cognitive Brain Age Biomarker Using its FDA-Cleared BNA Platform479KENMORE, N.Y., Jan. 14, 2025 (GLOBE NEWSWIRE) -- Firefly Neuroscience, Inc. ("Firefly" or the "Company") (NASDAQ: AIFF), an Artificial Intelligence ("AI") company developing innovative solutions that...
► Artikel lesen
Weiter >>
21 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1